Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer

SIMPLE SUMMARY: Given that most patients with MSS mCRC do not respond to immunotherapy agents or do not have durable clinical responses, there is an unmet clinical need to obtain predictors of response to immunotherapy and rational immunotherapy-based combination therapies for this entity. In this r...

Descripción completa

Detalles Bibliográficos
Autores principales: Baraibar, Iosune, Mirallas, Oriol, Saoudi, Nadia, Ros, Javier, Salvà, Francesc, Tabernero, Josep, Élez, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699573/
https://www.ncbi.nlm.nih.gov/pubmed/34944931
http://dx.doi.org/10.3390/cancers13246311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699573/
https://www.ncbi.nlm.nih.gov/pubmed/34944931
http://dx.doi.org/10.3390/cancers13246311

Ejemplares similares